TNF inhibitors were the cornerstones of treatment for RA, but now other biologics with different modes of actions have been developed, including IL-6 inhibitors (eg tocilizumab), rituximab (CD-20 monoclonal antibody) and abatacept (co-stimulatory molecule inhibitor), summarised in Table 1.3 Here, IL6 is linked to rheumatoid arthritis.